NFKB1 and cancer: As demonstrated by Briukhovetska D [13], IL-6 is capable of inducing angiogenesis through the activation of NF-κB, leading to the secretion of VEGF by cancer cells, promoting cell proliferation, invasion, and inhibiting apoptosis.